VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients

NCT00561925 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1068

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: nevirapine IR
DRUG: nevirapine XR

Sponsor

Boehringer Ingelheim